Our Products

ADMELOG
insulin lispro

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2302443 (v1.0)
Date of preparation: June 2023

ALDURAZYME
laronidase

Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2200954 (v3.0)
Date of preparation: October 2023

AUBAGIO
teriflunomide

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v4.0)
Date of preparation: April 2023

AVAXIM® Junior

Prescribing Information UK

MAT-XU-2301296 (v2.0)
Date of preparation: August 2023

AVAXIM®

Prescribing Information UK

MAT-XU-2301117 (v1.0)
Date of preparation: April 2023

Cablivi
caplacizumab

Prescribing Information GB
Prescribing Information NI

 

MAT-GB-2105168 (v6.0)
Date of preparation: October 2023

CERDELGA
eliglustat 84mg

Prescribing Information GB
Prescribing Information NI

MAT-XU-2204064 (v3.0)
Date of preparation: November 2023

CEREZYME
imiglucerase

Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2204065 (v2.0)
Date of preparation: January 2023


Clexane
enoxaparin


Prescribing Information UK

MAT-XU-2204397 (v2.0)
Date of preparation: May 2023

Fabrazyme
agalsidase beta

Prescribing Information GB
Prescribing Information NI

 

MAT-GB-2105812 (v4.0)
Date of preparation: May 2023

LANTUS
insulin glargine

Prescribing Information GB
Prescribing Information NI

MAT-XU-2201444 (v3.0)
Date of preparation: January 2023

LEMTRADA
Alemtuzumab

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

MenquadfiTM

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2301129 (v1.0)
Date of preparation: May 2023

MYOZYME
alglucosidase alfa

Prescribing Information GB
Prescribing Information NI

MAT-GB-2105179 (v3.0)
Date of preparation: February 2023

NEXVIADYME
avalglucosidase alfa

Prescribing Information GB
GB ONLY CONTENT

 

MAT-XU-2203480 (v5.0)
Date of preparation: September 2023

PRALUENT
alirocumab


Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2204604 (v2.0)
Date of preparation: March 2023

QIV®

Prescribing Information UK

MAT-XU-2301127 (v1.0)
Date of preparation: May 2023

REPEVAX®

Prescribing Information UK

MAT-XU-2301125 (v2.0)
Date of preparation: June 2023

REVAXIS®

Prescribing Information UK

MAT-XU-2301123 (v1.0)
Date of preparation: May 2023

REZUROCK
belumosudil tablets

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2202695 (v3.0)
Date of preparation: June 2023

SARCLISA
isatuximab

Prescribing Information GB
GB ONLY CONTENT

 

MAT-XU-2202578 (v2.0)
Date of preparation: August 2023

STAMARiL®

Prescribing Information UK

MAT-XU-2301130 (v1.0)
Date of preparation: May 2023

Supemtek®

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2301126 (v1.0)
Date of preparation: May 2023

TOUJEO
insulin glargine

Prescribing Information GB
Prescribing Information NI

MAT-XU-2302426 (v6.0)
Date of Preparation: October 2023 

TRURAPI
insulin aspart

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2205461 (v7.0)
Date of preparation: June 2023

TYPHIM Vi®

Prescribing Information UK

MAT-XU-2301128 (v1.0)
Date of preparation: May 2023

VAXELIS®

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2301124 (v1.0)
Date of preparation: May 2023

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.

MAT-GB-2105466 (v1.0)
Date of preparation: February 2022